Photodynamic therapy in Argentina

Photodiagnosis and Photodynamic Therapy

Volumn 3, Issue 4, 2006, Pages 205-213

  Casas, Adriana ^a   Batlle, Alcira ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

5 Aminolevulinic acid; ALA; Argentina; History; PDT; Photodynamic therapy

Indexed keywords

5 (4 ACETAMIDOPHENYL) 10,15,20 TRIS(4 METHOXYPHENYL)PORPHYRIN; 5 (4 AMINOPHENYL) 10,15,20 TRIS(2,4,6 TRIMETHOXYPHENYL)PORPHYRIN; 5 (4 TRIFLUOROPHENYL) 10,15,20 TRIS(4 TRIMETHYLAMMONIUMPHENYL)PORPHYRIN IODIDE; 5 [4 (TRIMETHYLAMMONIUM)PHENYL] 10,15,20 TRIS(2,4,6 TRIMETHOXYPHENYL) PORPHYRIN IODIDE; 5 [4 N (2',6' DINITRO 4' TRIFLUOROMETHYLPHENYL)AMINOPHENYL] 10,15,20 TRIS(2,4,6 TRIMETHOXYPHENYL)PORPHYRIN; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID METHYL ESTER; CYCLOPHOSPHAMIDE; CYTOCHROME P450; DIMETHYL SULFOXIDE; DOXORUBICIN; FERROCHELATASE; FLUOROURACIL; HEME OXYGENASE; LIPOSOME; NITRIC OXIDE; PHOTOSENSITIZING AGENT; PORPHOBILINOGEN DEAMINASE; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; UROPORPHYRINOGEN DECARBOXYLASE; ZINC TETRAMETHYLTETRAPYRIDINOPORPHYRAZINIUM; ZINC TETRAPYRIDINOPORPHYRAZINE;

ACTINIC KERATOSIS; ADENOCARCINOMA; ARGENTINA; ARTICLE; BACTERIAL CELL; BRAIN TUMOR; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL DEATH; COST; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; DRUG TRANSPORT; ELECTRON MICROSCOPY; EXPERIMENTAL MOUSE; EXPLANT; HUMAN; LIGHT; LIPOPHILICITY; LIVER TUMOR; MAMMAL CELL; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHYSICIAN; PLANT TISSUE; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; SKIN CARCINOMA; YEAST CELL;

BACTERIA (MICROORGANISMS); MAMMALIA; MURINAE;

EID: 33846092577     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2006.06.003     Document Type: Article

References (53)

1. Batlle A., Llambias E., Wider E., and Tigier H. Porphyrin biosynthesis in soybean callus system -XV. The effect of growth conditions. Int J Biochem 6 (1975) 591-606
2. Fukuda H., Paredes S., and Batlle A. Tumour-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms. Drug Des Deliv 5 (1989) 133-139
3. Fukuda H., Casas A., Chueke F., Paredes S., and Batlle A. Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoural cell killing. Int J Biochem 25 (1993) 1395-1398
4. Casas A., Fukuda H., Di Venosa G., and Batlle A. Photosensitisation and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer 85 (2001) 279-284
5. Fukuda H., Paredes S., and Batlle A. Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. Comp Biochem Physiol B 102 (1992) 433-436
6. Fukuda H., Paredes S., Casas A., Chueke F., and Batlle A. Potential of liposome-entrapped aminolevulinic acid in cancer therapy. Effect of prior injection of empty liposomes and different routes of administration. The Cancer J 5 (1992) 295-299
7. Dougherty T. Photodynamic Therapy (PDT) of malignant tumours. Crit Rev Oncol Hematol 2 (1984) 83-116
8. Navone N., Polo C., Frisardi A., and Batlle A. Mouse mammary carcinoma PBGase and hydroxymethylbilane synthetase. Comp Biochem Physiol B 98 (1991) 67-71
9. Van Hillesberg R., van der Berg J., Kort W., Terpstra O., and Wilson J. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology 103 (1992) 647-651
10. Navone N.M., Frisardi A.L., Resnik E.R., Batlle A., and Polo C. Porphyrin biosynthesis in human breast cancer. Preliminary mimetic in vitro studies. Med Sci Res 16 (1988) 61-62
11. Navone N.M., Polo C., Frisardi A.L., Andrade N.E., and Batlle A. Heme biosynthesis in human breast adenocarcinoma-mimetic in vitro studies and some heme enzymic activity levels. Int J Biochem 22 (1990) 1407-1411
12. Navone N.M., Vazquez E.S., Polo C., and Batlle A. Rhodanese and ALA-S in mammary tumour and liver from normal and tumour-bearing mice. Comp Biochem Physiol B 102 (1992) 83-85
13. Navone N.M., Polo C., Dinger R., and Batlle A. Heme regulation in mouse mammary carcinoma I. Effect of allyl isopropyl acetamide and veronal on ALA-S, Cyt P450 and Cytochrome oxidase. Int J Biochem 22 (1990) 1005-1008
14. Navone N.M., Polo C., Frisardi A.L., and Batlle A. Mouse mammary carcinoma ALA-D. Comp Biochem Physiol B 96 (1990) 729-731
15. Navone N.M., Afonso S., Polo C., and Batlle A. Uroporphyrinogen decarboxylase from mouse mammary carcinoma and liver of normal and tumour-bearing mice. Comp Biochem Physiol B 102 (1992) 87-92
16. Polo C., Vazquez E.S., and Batlle A. Regulation of heme pathway in regenerating mouse liver. Comp Biochem Physiol B 101 (1992) 243-246
17. Polo C., Vazquez S.E., Caballero A., Gerez E., and Batlle A. Heme biosynthesis in a model of precarcinogenesis pre-initiation. Comp Biochem Physiol B 103 (1992) 251-256
18. Casas A., Fukuda H., Riley P., and Batlle A. Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin. Cancer Lett 121 (1997) 105-113
19. Casas A., Fukuda H., and Batlle A. Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide. Cancer Biochem Biophys 16 (1998) 183-196
20. Fukuda H., Batlle A., and Riley P.A. Kinetics of porphyrin accumulation in cultured epithelial cells exposed to ALA. Int J Biochem 25 (1993) 1407-1410
21. Casas A., Fukuda H., Meiss R., and Batlle A. Topical and intratumoural photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma. Cancer Lett 141 (1999) 29-38
22. Casas A, Perotti C, Ortel B, DiVenosa G, Saccoliti M, Batlle A, Hasan T. Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells. Int J Oncol, in press.
23. Casas A., Fukuda H., and Batlle A. Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles. Br J Cancer 81 (1999) 13-28
24. Casas A., Fukuda H., Di Venosa G., and Batlle A. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitisation. Br J Dermatol 143 (2000) 564-572
25. Kloek J., and Beijersbergen van Henegouwen G. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 64 (1996) 994-1000
26. Gaullier J., Berg K., Peng Q., et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 57 (1997) 1481-1486
27. Casas A., and Batlle A. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Current Med Chem Anti-Cancer Agents 2 (2002) 465-475
28. Casas A., and Batlle A. Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy. Curr Med Chem 13 5 (2006) 1157-1168
29. Casas A., Batlle A., Butler A., Robertson D., MacRobert A., and Riley P. Comparative effect of ALA derivatives on Protoporphyrin IX production in human and rat skin organ cultures. Br J Cancer 80 (1999) 1525-1532
30. Casas A., Perotti C., Fukuda H., Rogers L., Butler A., and Batlle A. ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitisation. Br J Cancer 85 (2001) 1794-1800
31. Perotti C., Casas A., Fukuda H., Sacca P., and Batlle A. ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice. Br J Cancer 87 (2002) 790-795
32. DiVenosa G, Batlle A, Fukuda H, MacRobert A, Casas A. Distribution of 5-aminolevulinic acid derivatives in mice tissues. Cancer Chemother Pharmacol, in press.
33. Perotti C., Fukuda H., Di Venosa G., MacRobert A., Batlle A., and Casas A. Porphyrin synthesis from ALA derivatives for Photodynamic therapy. In vitro and in vivo studies. Br J Cancer 90 (2004) 1660-1665
34. DiVenosa G., Fukuda H., Batlle A., MacRobert A., and Casas A. Photodynamic therapy: regulation of porphyrin synthesis and hydrolysis from ALA esters. J Photochem Photobiol B Biol 83 (2006) 129-136
35. Bermudez Moretti M., Correa Garcia S., Chianelli M., Ramos E., and Batlle A. δ-Aminolevulinic acid uptake is mediated by the γ-aminobutyric acid-specific permease UGA4. Cell Mol Biol 42 (1996) 519-523
36. Bermudez Moretti M., Correa Garcia S., Perotti C., Batlle A., and Casas A. Delta-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters. Br J Cancer 87 (2002) 471-474
37. Rodriguez L., Batlle A., di Venosa G., Battah S., MacRobert A., and Casas A. Mechanisms of uptake of 5-aminolevulic acid esters in mammalian cells. Br J Pharmacol 147 (2006) 825-833
38. Rodríguez L., Batlle A., DiVenosa G., MacRobert A., Battah S., Daniel H., and Casas A. Study of the mechanisms of uptake of 5-aminolevulinic acid derivatives by PEPT1 and PEPT2 transporters as a tool to improve photodynamic therapy of tumours. Int J Biochem Cell Biol 38 (2006) 1530-1539
39. Casas A., Perotti C., Saccoliti M., Sacca P., Fukuda H., and Batlle A. ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures. Br J Cancer 86 (2002) 837-842
40. Ambade A., Savariar E., and Thayumanavan S. Dendrimeric micelles for controlled drug release and targeted delivery. Mol Pharm 2 (2005) 264-272
41. Battah S., Chee C., Nakanishi H., Gerscher S., MacRobert A., and Edwards C. Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy. Bioconjugate Chem 12 (2001) 980-988
42. Di Venosa G., Casas A., Battah S., et al. Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy. Int J Biochem Cell Biol 38 (2006) 82-91
43. DiVenosa G., Perotti C., Fukuda H., Batlle A., and Casas A. Sensitivity of cell lines with different nitric oxide production and resistance to NO cytotoxicity. J Photochem Photobiol B Biol 80 (2005) 195-202
44. DiVenosa G., Casas A., Fukuda H., Perotti C., and Batlle A. No cross resistance between ALA-mediated photodynamic therapy and nitric oxide. Nitric Oxide 13 (2005) 155-162
45. Spesia M., Lazzeri D., Pascual L., Rovera M., and Durantini E. Photoinactivation of Escherichia coli using porphyrin derivatives with different number of cationic charges. FEMS Immunol Med Microbiol 44 (2005) 289-295
46. Milanesio M., Alvarez M., Rivarola V., Silber J., and Durantini E. Porphyrin-fullerene C60 dyads with high ability to form photoinduced charge-separated state as novel sensitisers for photodynamic therapy. Photochem Photobiol 81 (2005) 891-897
47. Dupouy E., Lazzeri D., and Durantini E. Photodynamic activity of cationic and non-charged Zn(II)tetrapyridinoporphyrazine derivatives: biological consequences in human erythrocytes and Escherichia Coli. Photochem Photobiol Sci 3 (2004) 992-998
48. Lazzeri D., Rovera M., Pascual L., and Durantini E. Photodynamic studies and photoinactivation of Escherichia coli using meso-substituted cationic porphyrin derivatives with asymmetric charge distribution. Photochem Photobiol 80 (2004) 286-293
49. Milanesio M., Alvarez M., Silber J., Rivarola V., and Durantini E. Photodynamic activity of monocationic and non-charged methoxyphenylporphyrin derivatives in homogeneous and biological media. Photochem Photobiol Sci 2 (2003) 926-933
50. Alvarez M., Moran F., Yslas E., et al. Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative. Biomed Pharmacother 57 (2003) 163-168
51. Pittau R., Pons P., Boeto N., and Aoki A. An inexpensive light source for oncologic photodynamic therapy. IEEE Eng Med Biol Mag 17 (1998) 105-106
52. Pons P., Pittau R.F., Boetto N.A., Garzon R., and Aoki A. Prototype of light source for photodynamic therapy in Centre of Electron Microscopy. Rev Fac Cien Med Univ Nac Cordoba 57 (2000) 31-36
53. Pons P., Pittau R., Boetto N., Garzon R., and Aoki A. Terapia Fotodinámica de neoplasias dérmicas: experiencia de dos años. Rev Argent Dermatol 82 (2001) 208-215